Evommune (EVMN) Return on Equity (2025)
Evommune (EVMN) has disclosed Return on Equity for 1 consecutive years, with 4.0% as the latest value for Q4 2025.
- On a quarterly basis, Return on Equity changed N/A to 4.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 4.0%, a N/A change, with the full-year FY2025 number at 2.54%, changed N/A from a year prior.
- Return on Equity was 4.0% for Q4 2025 at Evommune.
- In the past five years, Return on Equity ranged from a high of 4.0% in Q4 2025 to a low of 4.0% in Q4 2025.